Aller au contenu Aller au menu Aller à la recherche

accès rapides, services personnalisés
Rechercher
Chimie moléculaire Paris Centre
ÉCOLE DOCTORALE 406

Therapy with CO: where do we stand ?

Séminaire du Pr Carlos C. Romão (Universidade Nova de Lisboa - ITQB NOVA)

Abstract :

The promise to use CO (carbon monoxide) as a therapeutic principle appeared with the turn of the century following the discovery of CO’s signalling and cytoprotective effects. The ensuing research effort confirmed the therapeutic action of CO. Inhaled CO gas has been tested in many human clinical trials. Different kinds of organometallic and organic prodrugs and a large variety of materials and devices have been successfully tested. However, CO has not yet entered the clinic and the question to ask is: why? The meanders and highlights of this journey will be discussed in an attempt to identify the reasons for this impasse and outline reasonable pathways to overcome it. .

25/10/18

Traductions :

    Contact

    Directeur

    cyril.ollivier@sorbonne-universite.fr (cyril.ollivier @ upmc.fr)

     

    Directeur adjoint

     

     

    Secrétariat

    Irène Rasoarinoro (irene.rasoarinoro @ upmc.fr)

    Tel. : 01 44 27 38 48

     

    UPMC - ED 406

    Tour 32 - 42

    Bureau 114 (1er étage)

    BC 63 - 4 Place Jussieu 

    75252 Paris cedex 5